Literature DB >> 23375062

Assessment and risk reduction in lymphedema.

Michael Bernas1.   

Abstract

OBJECTIVES: To inform oncology nurses about current concepts and practices for the diagnosis and assessment of patients with cancer-related lymphedema and to examine risk-reduction strategies. DATA SOURCES: Peer reviewed literature.
CONCLUSION: Although there is not an established, standardized protocol for the assessment of these patients, multiple diagnostic and assessment tools are available and in use. In a clinical setting for comprehensive lymphedema care, development of assessment protocols that are reproducible and utilized over the course of care is necessary. Risk-reduction strategies for lymphedema are an emerging focus in oncology care. IMPLICATIONS FOR NURSING PRACTICE: Established methods for diagnosis and assessment are available and should be incorporated into practice. Risk-reduction strategies should be considered.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23375062     DOI: 10.1016/j.soncn.2012.11.003

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  7 in total

1.  Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery.

Authors:  Geraldine Leung; Christina Baggott; Claudia West; Charles Elboim; Steven M Paul; Bruce A Cooper; Gary Abrams; Anand Dhruva; Brian L Schmidt; Kord Kober; John D Merriman; Heather Leutwyler; John Neuhaus; Dale Langford; Betty J Smoot; Bradley E Aouizerat; Christine Miaskowski
Journal:  Lymphat Res Biol       Date:  2014-02-06       Impact factor: 2.589

2.  A data engineering framework for on-site end-of-life industrial operations.

Authors:  Jose D Hernandez-Betancur; Mariano Martin; Gerardo J Ruiz-Mercado
Journal:  J Clean Prod       Date:  2021-12       Impact factor: 9.297

3.  The legacy of lymphedema: Impact on nursing practice and vascular access.

Authors:  Gail Larocque; Sheryl McDiarmid
Journal:  Can Oncol Nurs J       Date:  2019-07-01

4.  Best Practice Guidelines in Assessment, Risk Reduction, Management, and Surveillance for Post-Breast Cancer Lymphedema.

Authors:  Jane M Armer; Jennifer M Hulett; Michael Bernas; Pam Ostby; Bob R Stewart; Janice N Cormier
Journal:  Curr Breast Cancer Rep       Date:  2013-06

5.  Data engineering for tracking chemicals and releases at industrial end-of-life activities.

Authors:  Jose D Hernandez-Betancur; Gerardo J Ruiz-Mercado; John P Abraham; Mariano Martin; Wesley W Ingwersen; Raymond L Smith
Journal:  J Hazard Mater       Date:  2020-10-16       Impact factor: 10.588

6.  Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema.

Authors:  Pamela L Ostby; Jane M Armer; Paul S Dale; Margaret J Van Loo; Cassie L Wilbanks; Bob R Stewart
Journal:  J Pers Med       Date:  2014-08-18

7.  Worse and worse off: the impact of lymphedema on work and career after breast cancer.

Authors:  John Boyages; Senia Kalfa; Ying Xu; Louise Koelmeyer; Helen Mackie; Hector Viveros; Lucy Taksa; Paul Gollan
Journal:  Springerplus       Date:  2016-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.